AI assistant
Sending…
Vistin Pharma — Director's Dealing 2020
Aug 28, 2020
3782_dirs_2020-08-28_06cf92d8-579b-40fd-a748-c6109329ca50.html
Director's Dealing
Open in viewerOpens in your device viewer
Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA: Mandatory notification of trade
Kjell-Erik Nordby, CEO of Vistin Pharma ASA, and a primary insider, has on
Friday 28(th) of August 2020 sold 100 000 shares in Vistin Pharma ASA at an
average price of NOK 16.28 per share. Following this transaction, Kjell-Erik
Nordby holds 100 000 shares in Vistin Pharma ASA.
More from Vistin Pharma
Notice of Dividend Amount
2026
May 22
AGM Information
2026
May 20
Report Publication Announcement
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 28
Remuneration Information
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report
2026
Apr 28
Annual Report
2026
Apr 28
AGM Information
2026
Apr 28